Related Experiment Video
Updated: Jun 13, 2025
Intrastriatal Injection of Autologous Blood or Clostridial Collagenase as Murine Models of Intracerebral Hemorrhage
Published on: July 3, 2014
Novel Therapeutic Mechanisms and Strategies for Intracerebral Hemorrhage: Focusing on Exosomes
Shandong Jiang1,2, Libin Hu1,2, Hang Zhou1,2
1Department of Neurosurgery, Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, 310016, People's Republic of China.
Insights
Exosomes, tiny vesicles carrying microRNAs (miRNAs), show promise for treating intracerebral hemorrhage (ICH). These natural nanoparticles offer a novel therapeutic strategy to improve outcomes for ICH patients by targeting key biological pathways.
Area of Science:
- Neuroscience
- Biotechnology
- Cell Biology
Background:
- Intracerebral hemorrhage (ICH) is a severe neurological condition with high mortality and limited treatment options.
- Exosomes, extracellular vesicles containing microRNAs (miRNAs), are crucial for intercellular communication.
- Exosomes possess favorable characteristics for therapeutic applications, including stability and low immunogenicity.
Purpose of the Study:
- To review the therapeutic potential of exosomes in treating intracerebral hemorrhage (ICH).
- To explore the mechanisms by which exosome-derived miRNAs influence ICH pathology.
- To discuss the challenges and future directions for clinical translation of exosome-based therapies for ICH.
Main Methods:
- Literature review of studies investigating exosome therapy for ICH.
- Analysis of exosome composition, particularly miRNA cargo.
- Examination of preclinical data on exosome efficacy in ICH models.
Main Results:
- Exosomes demonstrate therapeutic benefits in ICH through anti-apoptotic, neurogenic, angiogenic, anti-inflammatory, immunomodulatory, and autophagic mechanisms.
- miRNAs encapsulated within exosomes are key mediators of these beneficial effects.
- Exosomes can be engineered to deliver specific therapeutic agents, enhancing their potential.
Conclusions:
- Exosomes represent a promising cell-free therapeutic strategy for intracerebral hemorrhage.
- Targeted delivery of miRNAs via exosomes offers a novel approach to improve ICH prognosis.
- Further research is needed to overcome challenges and facilitate the clinical translation of exosome-based ICH treatments.
Abstract:
Intracerebral hemorrhage (ICH) is a primary, non-traumatic cerebral event associated with substantial mortality and disability. Despite advancements in understanding its etiology and refining diagnostic techniques, a validated treatment to significantly improve ICH prognosis remains elusive. Exosomes, a subtype of extracellular vesicles, encapsulate bioactive components, predominantly microRNAs (miRNAs), facilitating and regulating intercellular communication. Currently, exosomes have garnered considerable interests in clinical transformation for their nanostructure, minimal immunogenicity, low toxicity, inherent stability, and the ability to traverse the blood-brain barrier. A wealth of studies has demonstrated that exosomes can improve the prognosis of ICH through anti-apoptosis, neurogenesis, angiogenesis, anti-inflammation, immunomodulation, and autophagy, primarily via the transportation or overexpression of selected miRNAs. More importantly, exosomes can be easily customized with specific miRNAs or bioactive compounds to establish delivery systems, broadening their potential applications. This review focuses on the therapeutic potential of exosomes in ICH, reviewing the mechanisms of molecular biology mediated by certain miRNAs, discussing the benefits, challenges, and future prospects in ICH treatment. We hope comprehensive understanding of exosomes based on miRNAs will provide new insights into the treatment of ICH and guide the translation of exosome's research from laboratory to clinical practice.
